Patents by Inventor GE HEALTHCARE LIMITED

GE HEALTHCARE LIMITED has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130225829
    Abstract: The invention relates to a process for preparation of a compound of formula (I): R1 is selected from C1-6alkyl, C2-6alkenyl, and C2-6alkynyl; which comprises: (i) reaction with fluoride, suitably [18F]fluoride, of a corresponding compound of formula (II): wherein R2 is selected from hydrogen, C1-10alkyl, C1-10haloalkyl, C6-14aryl, C6-14arylalkyl, —(CH2CH2O)q—CH3 wherein q is an integer of from 1 to 10; R1 is as defined for the compound of formula (I); and R3 is a leaving group. Certain novel precursors of formula (II) and radiopharmaceutical kits containing such precursors are also claimed.
    Type: Application
    Filed: March 22, 2013
    Publication date: August 29, 2013
    Applicants: GE HEALTHCARE AS, GE HEALTHCARE LIMITED
    Inventors: GE HEALTHCARE LIMITED, GE HEALTHCARE AS
  • Publication number: 20130209358
    Abstract: The present invention relates to [18F]-fluciclatide radiopharmaceutical compositions, which are stabilised with a radioprotectant. Also described are methods for the preparation of the radiopharmaceutical compositions, including automated synthesizer methods and cassettes for use in such methods. The invention also includes methods of imaging the mammalian body using the radiopharmaceutical compositions.
    Type: Application
    Filed: February 11, 2013
    Publication date: August 15, 2013
    Applicant: GE HEALTHCARE LIMITED
    Inventor: GE HEALTHCARE LIMITED
  • Publication number: 20130129625
    Abstract: The present invention relates to the field of medical imaging, and in particular to imaging of disease states associated with the upregulation of the chemokine receptor 5 (CCR5). Imaging agents, precursors and methods are provided which are useful in imaging such disease states.
    Type: Application
    Filed: December 18, 2012
    Publication date: May 23, 2013
    Applicants: HAMMERSMITH IMANET LIMITED, GE HEALTHCARE LIMITED
    Inventors: GE Healthcare Limited, Hammersmith Imanet Limited
  • Publication number: 20130129626
    Abstract: The present invention relates to the field of medical imaging, and in particular to imaging of disease states associated with the upregulation of the chemokine receptor 5 (CCR5). Imaging agents, precursors and methods are provided which are useful in imaging such disease states.
    Type: Application
    Filed: December 18, 2012
    Publication date: May 23, 2013
    Applicants: HAMMERSMITH IMANET LIMITED, GE HEALTHCARE LIMITED
    Inventors: GE Healthcare Limited, Hammersmith Imanet Limited
  • Publication number: 20130101509
    Abstract: The present invention relates to in vivo imaging and radiotherapeutic methods and agents which target the enzyme aldehyde dehydrogenase (ALDH) and that are suitable for the in vivo imaging of tumours and treatment of cancer.
    Type: Application
    Filed: September 19, 2012
    Publication date: April 25, 2013
    Applicants: GENERAL ELECTRIC COMPANY, GE HEALTHCARE LIMITED
    Inventors: GE HEALTHCARE LIMITED, GENERAL ELECTRIC COMPANY
  • Publication number: 20130089501
    Abstract: The invention provides a process for the production of an 18F-labelled tracer which comprises treatment of a solid support-bound precursor of formula (I) SOLID SUPPORT-LINKER-X-TRACER??(I) wherein X is a group which promotes nucleophilic substitution at a specific site on the attached TRACER and the TRACER is of formula (A)
    Type: Application
    Filed: November 28, 2012
    Publication date: April 11, 2013
    Applicants: HAMMERSMITH IMANET LIMITED, GE HEALTHCARE LIMITED
    Inventors: GE HEALTHCARE LIMITED, HAMMERSMITH IMANET LIMITED